VHL and renal cell adenocarcinoma: In patients with low stage RCC (stages T1–T2), most somatic mutations captured in the tumor tissue were not detectable in either cfDNA or evDNA; however, we did detect a somatic stop-gain mutation of VHL (c.481C > T) in cfDNA sample of patient P2 who was affected by stage T1a tumor.